Nasal CPAP appears to work primarily as a pneumatic splint which passively opens the upper airway, thus precluding obstructive apneas. 7 Patient compliance has been shown to be as high as 75 percent, although some patients complain of mask discomfort, nasal dryness, and congestion. 8 We have found a slightly better compliance in our laboratory due to very close outpatient follow-up. Several of our patients, however, have raised questions about the adequacy of the mask pressure because of persistent daytime sleepiness. Others have wondered whether the pressure could be lowered in an effort to decrease mask discomfort. Because of a four-to six-week backlog in our scheduling, it became increasingly difficult to bring these patients back to the sleep laboratory to monitor them on nasal CPAE Further, questions have been raised about third-party reimbursement for these follow-up studies. It became apparent to us that it would be helpful if a monitoring system was available for determination of nasal CPAP efficacy in the patients home. With the help of one of our patients, a computer engineer, a portable pressure sensing system (PSS) was developed and tested.
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MATERIALS AND METHODS

Materials
The system consisted of a solid-state pressure sensor (Micro Switch 1PC01D36) with a range of approximately ± 13 cm HsO and a maximum pressure tolerance of 5 psi. The device was powered by a Radio Shack 9-V Adapter (270-1552) which could be plugged into a standard 110-V electric outlet. Plastic oxygen tubing connected the pressure sensor to the side port on the nasal CPAP mask (Respironics, Inc). The electric output from the pressure sensor was fed into a Biox 2100 strip chart recorder (Ohmeda), which was set to run at a speed of 3 cm/min.
Validation Procedure
The initial part of the protocol involved validation of the PSS against standard polysomnography. Ten patients with documented obstructed sleep apnea were studied with all-night polysomnography in the sleep apnea laboratory at Rhode Island Hospital. Sleep stages were monitored with an electroencephalographic (EEC) lead, bilateral electro-occulograms, and a submental electromyogram (EMG). Sleep was characterized using the system of Rechtschaffen and Kales. 9 Respiration was monitored using oral and nasal thermistors, surface intercostal EMGs, and pulse oximetry (Biox 3A oximeter, Ohmeda). Signals were recorded on a 17-channel polygraph (Nihon-Kohden).
The patients were fitted with a nasal CPAP mask connected to a blower unit (Sleep Easy, Respironics, Inc). Five of the subjects were tested using the original Respironics system which provided positive airway pressure throughout the respiratory cycle. The remaining five used the modified-Sanders circuit (Respironics, Inc). There is a valve in this circuit that allows airflow to reach the nose and pharynx only during inspiration, although there is positive pressure within the mask throughout the ventilatory cycle. Plastic oxygen tubing connected the mask to the solid-state pressure sensor. The electric output from the sensor in this part of the study was recorded not only on the strip chart recorder, but also on one of the channels of the polygraph to allow for easier comparison between the two methods.
The patients were allowed to go to sleep with the mask at the lowest pressure setting (3 to 5 cm H20). As apneas and hypopneas appeared, the pressure was slowly increased to a level at which all respiratory events were obliterated. The pressure was maintained at this level until morning.
The two sets of records were independently scored and then compared. An apnea was noted on the polysomnographic tracings if there was a total absence of airflow associated with an oxygen desaturation of at least 4 percent and in most instances associated with an arousal from sleep. A hypopnea was noted if there was a partial decrease in airflow associated with a 4 percent or greater fall in oxygen saturation and an EEC arousal. In a similar manner, the signals from the PSS device on the strip chart recording were also scored. An apnea was counted if the pressure signal remained fiat; a hypopnea was noted if there was a 50 percent or more decrease in the pressure deflection. The sensitivity of the PSS device was determined by dividing the true positives by the number of respiratory events detected by standard polysomnography. The positive predictive value was determined by dividing the true positives by the total number of events recorded by the PSS device. The length of the episodes observed by the two methods were compared by linear regression techniques.
Home Feasibility Study
The device was brought to the home of each of 23 patients after they had been on nasal CPAP for a minimum of ten days. A registered respiratory therapist (S.C.B.) confirmed that they were using the nasal CPAP system correctly and instructed them in how to connect the PSS device to their CPAP mask and how to turn it on. The therapist then adjusted the pressure tracings on to the middle of the strip chart paper as the subject breathed through the CPAP mask with the blower on. The PSS device was left in the patient's home, and recordings were made for two nights. The recordings from these nighttime studies were reviewed by a physician (R.P.M.) who counted the total number of apneas and hypopneas for each night. If multiple apneas or hypopneas were noted and the patient was still experiencing daytime sleepiness, the CPAP mask pressure was increased by 2.5 cm H20. A home monitoring test was then repeated.
RESULTS
Representative respiratory patterns detected by the PSS device are shown in Figure 1 . These patterns were not affected by body position. 
DISCUSSION
This study demonstrates that home monitoring of nasal CPAP patients is feasible and provides an accurate assessment of CPAP efficacy. A solid-state pressure sensor provides a very sensitive index of apnea and hypopnea frequency as well as duration. The use of the device at home allows not only for confirmation of CPAP efficacy in patients who are clinically improved, but also for readjustment of their CPAP pressure if symptoms persist. Further, the use of the home monitoring device alerts the physician to coexistent medical problems, as in the two patients who had narcolepsy and mild hypothyroidism, respectively. The device was easily used by the patients, and the technical problems were mild-a lack of paper and ink supplies.
The device works by sensing changes in pressure within the CPAP mask and thus reflects changes in tidal volume. This differs from oral and nasal thermistors which are detecting changes in airflow. Thermistors cannot really differentiate changes in tidal volume. There are several possible reasons why the mask pressure had to be increased in eight patients after they had been on nasal CPAP at home. One possibility is that an inaccurate assessment was made of the pressure requirements while they were in the sleep laboratory. Another possibility is that the patients developed increased nasal congestion with the use of nasal CPAP and, thus, a higher nasal resistance. At a fixed airflow rate the effective CPAP pressure would thus fall. Since nasal congestion is often noted in sleep apnea patients on nasal CPAP N we are now routinely using a topical nasal steroid inhaler or a long-acting antihistamine-decongestant at bedtime in these patients. In addition, the patients may have been consuming alcoholic beverages at home; they were specifically directed to avoid alcohol during the nights they were studied. Alcohol, by decreasing upper airway muscle tone, 10 would increase nasopharyngeal resistance and increase nasal pressure requirements.
It is also theoretically possible that the patient could be putting the mask on inappropriately, causing a leak. 
